JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
CALL
TJX Companies
TJX
$148B
| $17.5M | ﹤0.01% |
144,500
+80,000
| +124% | +$9.55M |
2021 Q4
12 quarters
|
|
2127
CALL
Intuitive Surgical
ISRG
$144B
| $17.4M | ﹤0.01% |
33,400
-2,400
| -7% | -$1.25M |
2017 Q2
30 quarters
|
|
2128
PUT
Datadog
DDOG
$99.3B
| $17.4M | ﹤0.01% |
122,000
+110,000
| +917% | +$15.1M |
2023 Q3
5 quarters
|
|
2129
PUT
Cummins
CMI
$72B
| $17.4M | ﹤0.01% |
49,900
-2,800
| -5% | -$984K |
2021 Q3
13 quarters
|
|
2130
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.41B
| $17.4M | ﹤0.01% |
544,384
+249,987
| +85% | +$8.15M |
2017 Q4
28 quarters
|
|
2131
NIO
NIO
$8.57B
| $17.4M | ﹤0.01% |
3,986,722
+1,575,898
| +65% | +$8.02M |
2019 Q1
23 quarters
|
|
2132
Barclays
BCS
$78.7B
| $17.4M | ﹤0.01% |
1,307,141
+489,281
| +60% | +$6.34M |
2013 Q2
46 quarters
|
|
|
MZTI
2133
The Marzetti Company
MZTI
$2.72B
| $17.3M | ﹤0.01% |
100,162
+38,583
| +63% | +$7.06M |
2014 Q3
41 quarters
|
|
|
PTVE
2134
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $17.3M | ﹤0.01% |
992,517
+507,795
| +105% | +$6.87M |
2020 Q3
17 quarters
|
|
2135
CALL
VanEck Durable High Dividend ETF
DURA
$36.9M
| $17.3M | ﹤0.01% |
63,800
+50,000
| +362% | +$1.71M |
2021 Q3
13 quarters
|
|
2136
Arrow Electronics
ARW
$12.2B
| $17.3M | ﹤0.01% |
152,554
-163,246
| -52% | -$20.2M |
2013 Q2
46 quarters
|
|
2137
iShares US Regional Banks ETF
IAT
$612M
| $17.3M | ﹤0.01% |
342,559
-22,151
| -6% | -$1.14M |
2020 Q1
19 quarters
|
|
2138
Veracyte
VCYT
$3.83B
| $17.2M | ﹤0.01% |
434,971
+88,384
| +26% | +$3.35M |
2017 Q3
29 quarters
|
|
|
ACLX
2139
DELISTED
Arcellx
ACLX
| $17.2M | ﹤0.01% |
224,456
-25,667
| -10% | -$2.22M |
2022 Q1
11 quarters
|
|
2140
Voya Financial
VOYA
$8.89B
| $17.2M | ﹤0.01% |
249,935
+30,419
| +14% | +$2.38M |
2013 Q2
46 quarters
|
|
2141
PUT
Snowflake
SNOW
$120B
| $17.2M | ﹤0.01% |
111,300
+79,000
| +245% | +$11.1M |
2020 Q4
16 quarters
|
|
2142
Fidelity MSCI Information Technology Index ETF
FTEC
$22.7B
| $17.2M | ﹤0.01% |
92,841
-35,807
| -28% | -$6.54M |
2015 Q4
36 quarters
|
|
2143
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$893M
| $17.1M | ﹤0.01% |
399,227
+137,873
| +53% | +$6.02M |
2023 Q2
6 quarters
|
|
2144
Central Pacific Financial
CPF
$936M
| $17.1M | ﹤0.01% |
589,609
+158,111
| +37% | +$4.7M |
2013 Q2
46 quarters
|
|
|
AAT
2145
American Assets Trust
AAT
$1.31B
| $17.1M | ﹤0.01% |
652,216
+67,687
| +12% | +$1.85M |
2013 Q2
46 quarters
|
|
2146
Kirby Corp
KEX
$7.38B
| $17.1M | ﹤0.01% |
161,495
+19,230
| +14% | +$2.32M |
2013 Q2
46 quarters
|
|
2147
Axsome Therapeutics
AXSM
$9.28B
| $17.1M | ﹤0.01% |
201,902
-10,208
| -5% | -$939K |
2019 Q2
22 quarters
|
|
2148
CALL
Western Digital
WDC
$159B
| $17M | ﹤0.01% |
377,849
-42,336
| -10% | -$2.13M |
2023 Q4
4 quarters
|
|
2149
PUT
Accenture
ACN
$119B
| $17M | ﹤0.01% |
48,400
-12,400
| -20% | -$4.46M |
2021 Q2
14 quarters
|
|
|
EMBJ
2150
Embraer S.A. ADS
EMBJ
$13.4B
| $17M | ﹤0.01% |
464,002
+242,649
| +110% | +$8.74M |
2013 Q2
46 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.